Navigation Links
Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
Date:6/22/2013

iflozin 10 mg or 25 mg given for 24 weeks as monotherapy or add-on to existing therapy, including metformin, metformin plus sulfonylurea, or pioglitazone with or without metformin.1,2 Baseline HbA1c levels were 8.02 percent for the placebo group, 7.98 percent for the empagliflozin 10 mg group, and 7.96 percent for the empagliflozin 25 mg group.1,2

The placebo-adjusted efficacy results at 24 weeks for empagliflozin included:

  • Reductions in HbA1c of 0.62 percent and 0.68 percent (p<0.001) for 10 mg and 25 mg, respectively1
  • Decreases in FPG levels of 27.9 mg/dL and 30.6 mg/dL (p<0.001) for 10 mg and 25 mg, respectively1
  • Loss of 3.99 lbs and 4.43 lbs (p<0.001) in body weight for 10 mg and 25 mg, respectively1
  • Reductions in systolic blood pressure of 3.4 mmHg and 3.8 mmHg (p<0.001) with 10 mg and 25 mg, respectively1
  • Reductions in diastolic blood pressure of 1.2 mmHg and 1.5 mmHg (p<0.001) with 10 mg and 25 mg, respectively1
  • Reductions in uric acid of 0.50 mg/dL and 0.49 mg/dL (p<0.001 vs. placebo) with 10 mg and 25 mg, respectively, versus an increase of 0.02 mg/dL for placebo1
  • Changes in lipid parameters including:
    • LDL cholesterol (bad cholesterol) increased (3.1 mg/dL for 10 mg [p=0.060] and 3.9 mg/dL for 25 mg [p=0.008 vs. placebo]) versus an increase of 0.8 mg/dL for placebo1
    • HDL cholesterol (good cholesterol) increased (2.7 mg/dL for 10 mg and 25 mg; p<0.001 vs. placebo) versus a change of 0.0 mg/dL for placebo1
    • Triglycerides decreased (9.7 mg/dL for 10 mg [p=0.011 vs. placebo] and 1.8 mg/dL for 25 mg [p=0.321]) versus an increase of 2.7 mg/dL for placebo1

For po
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
2. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
3. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
4. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
5. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
6. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
9. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
10. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
11. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... today lauded the latest results achieved by the ... known as the National Precursor Log Exchange (NPLEx), ... enforcement officials track down methamphetamine offenders and make ... in Michigan blocked the ...
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
(Date:8/21/2014)... Living in a quality residential community means ... with it. A quality Home Owners Association like the ... available. , Simpson Mill Plantation, ... Association Management, LLC made a recent investment in a ... an additional amenity for their neighborhood. , Situated near ...
(Date:8/21/2014)... 21, 2014 Recently, Van Uden ... patients. Alternative medicine is on the rise and ... According to The Fiscal Times, young people are ... conventional medicine. , The Fiscal Times published an ... are embracing alternative medicine. The article can be ...
(Date:8/21/2014)... the coronary arteries of chronic kidney disease patients may ... to a new study in the Journal of ... Researchers at the Johns Hopkins Bloomberg School of Public ... used measures of subclinical atherosclerosis in predicting the risk ... Approximately 50 percent of all patients with chronic kidney ...
(Date:8/21/2014)... cancer appear to have better survival if they ... Author: Uchechukwu C. Megwalu, M.D., M.P.H., of the ... York, and colleagues. , Background: Approximately 11,000 to ... year and squamous cell carcinoma accounts for the ... total surgical removal of the larynx with postoperative ...
(Date:8/21/2014)... Improv performers from Fun House Theatre and Film ... Turtle Creek memory care community in Dallas. The Unicorn ... ages 10 to 16, delivers a groundbreaking and fun-filled ... troupe's philosophy is that improv is based on relationships, ... audiences regardless of their circumstance — including bringing joy ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2
... Citizens by Enhancing Their ... Own Plans, ... help them prepare for one of the most daunting public,health emergencies: an ... Policy (CIDRAP) at,the University of Minnesota and the Pew Center on the ...
... Organization Urges Consumers to ... Beware!, ... Society of Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision ... of Healing Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still ...
... or circulating tumour cells (CTCs), are known to be associated ... Now, for the first time, a group of scientists have ... chemotherapy treatment and hence may be able to identify those ... such treatment in future. , Dr. Julia Jckstock, from the ...
... Driven by Launches, of Disease-Modifying Therapies, According to a New ... ... Resources, WALTHAM, Mass., Sept. 24 Decision Resources, one of ... that by 2016 Genentech/Roche,s Lucentis and Eli,Lilly,s ruboxistaurin will drive the ...
... DUBLIN, Ohio, Sept. 24 Cardinal Health, a,global provider ... of health care, today announced President and Chief Executive,Officer ... effective Nov. 8,following the company,s 2007 annual shareholder meeting. ... who plans to retire,at the end of the company,s ...
... University of Warwick, and University College London, have found that ... death from cardiovascular disease. However they have also found that ... double the risk of death. , In research to be ... Society, Professor Francesco Cappuccio from the University of Warwicks Warwick ...
Cached Medicine News:Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 3Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 4Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 5Health News:Lipodissolve - Is it Safe??? 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 3Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 3Health News:Researchers say lack of sleep doubles risk of death... but so can too much sleep 2
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
... Scrub Care povidone-iodine (PVP-I) antimicrobial solutions ... control in all hospital and health-care settings. ... gel have a broad spectrum of activity, ... bacteria that may cause infection. The new ...
... hand sanitizers like Aplicare No Rinse Isopropyl ... as the recommended product for hand disinfection ... Guidelines for hand hygiene., According to the ... be prevented with better infection control programs. ...
This is long known for its purity and mildness, Castile Soap is also an effective cleaning agent that is used in a variety of applications. It rinses clean while leaving the skin soft and healthy....
Medicine Products: